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When cellular glucose concentrations fall below normal lev-
els, in general the extent of protein O-GlcNAc modification
(O-GlcNAcylation) decreases. However, recent reports de-
monstrated increased O-GlcNAcylation by glucose deprivation
in HepG2 and Neuro-2a cells. Here, we report increased
O-GlcNAcylation in non-small cell lung carcinoma A549 cells
and various other cells in response to glucose deprivation.
Although the level ofO-GlcNAc transferase was unchanged, the
enzyme contained lessO-GlcNAc, and its activitywas increased.
Moreover,O-GlcNAcase activity was reduced. The studied cells
contain glycogen, and we show that its degradation in response
to glucose deprivation provides a source for UDP-GlcNAc
required for increased O-GlcNAcylation under this condition.
This required active glycogen phosphorylase and resulted in
increased glutamine:fructose-6-phosphate amidotransferase,
the first and rate-limiting enzyme in the hexosamine biosyn-
thetic pathway. Interestingly, glucose deprivation reduced the
amount of phosphofructokinase 1, a regulatory glycolytic en-
zyme, and blocked ATP synthesis. These findings suggest that
glycogen is the source for increased O-GlcNAcylation but not
for generating ATP in response to glucose deprivation and that
this may be useful for cancer cells to survive.
Extracellular glucose is transferred into cells by glucose
transporters (1, 2), where it is rapidly converted into glucose
6-phosphate by hexokinase. Glucose 6-phosphate is either used
for glycogen synthesis or enters the glycolytic pathway after
conversion to fructose 6-phosphate. Most of the transferred
glucose is used for ATP synthesis through the glycolytic path-
way and the tricarboxylic acid cycle. Only about 2–5% of the
transferred glucose enters the hexosamine biosynthetic path-
way (HBP)3 and is converted into uridine 5-diphospho-N-
acetylglucosamine (UDP-GlcNAc) (3). UDP-GlcNAc is trans-
ferred by O-GlcNAc transferase (OGT) to serine or threonine
residues to yield the single O-linked -N-acetylglucosamine
(O-GlcNAc)modification (4). UDP-GlcNAc represents a nutri-
ent sensor being the product of various metabolic pathways
such as the glucose, fatty acid, amino acid, nucleotide, and
energy metabolism (5, 6). Because protein O-GlcNAc modifi-
cation (O-GlcNAcylation for brevity) by OGT is highly depen-
dent onUDP-GlcNAc concentration,O-GlcNAcmetabolism is
thought to have a critical role in nutrient homeostasis (5, 6).
Since its first description as a novel posttranslational protein
modification by Torres and Hart (7), 600 proteins as diverse
as transcription factors, enzymes, cytoskeletal proteins, and
ribosomal proteins have been identified to carry O-linked
GlcNAc (4–6). Thus, protein O-GlcNAcylation appears to be
involved in many different cellular activities, which include the
regulation of transcription and translation (8–12), of protein
degradation (12–16), and localization (17), as well as of protein-
protein interactions (13, 18). Of particular interest are reports
thatO-GlcNAcylation of nucleocytoplasmic proteins can occur
under various forms of cellular stress such as heat shock, UV
light, and high salt concentration (19, 20). Under such condi-
tions, the O-GlcNAcylation may have a function for cell sur-
vival, but the mechanism is not clear.
Recently, it was reported that glucose deprivation
increases protein O-GlcNAcylation in HepG2 (21) and
Neuro-2a cells (22). Further studies have revealed the
dynamics of O-GlcNAcylation in HepG2 cells during glucose
deprivation and have shown that up-regulation of OGT is
mediated by decreasedHBP flux (23). In light of the abovemen-
tioned importance of glucose as a source for UDP-GlcNAc syn-
thesis and thus protein O-GlcNAcylation, increased O-Glc-
NAcylation under glucose deprivation appears paradoxical.
However, it may provide a clue for the importance of the
O-GlcNAcylation as a nutrient sensor, in glucose homeostasis,
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and for cell survival. We observed increased protein O-Glc-
NAcylation in glucose-deprived A549 lung cancer cells and
other cell lines, similar to that reported for HepG2 and
Neuro-2a cells (21, 22). However, we observe that increased
O-GlcNAcylation in response to glucose deprivation was not
due to up-regulated OGT (21, 22) and not dependent on the
activation of AMP-activated protein kinase (AMPK) (22).
It was reported that inhibition of glycogen phosphorylase
(GP), which catalyzes glycogen degradation, suppressed the
growth of A549 cells (24), but the role of glycogen in cancer
biology is not well understood. We demonstrate here that gly-
cogen is a source for protein O-GlcNAcylation in glucose-de-
prived A549 cells. Thus, protein O-GlcNAcylation in tumors
may have a function in overcoming the effects of hypoxia and
hypoglycemia. Our findings have the interesting implication
thatO-GlcNAcylationmay act as an intermediary between glu-
cose and glycogen metabolism in cancer cells.
EXPERIMENTAL PROCEDURES
Cell Culture, Glucose Deprivation, and Inhibitor Treatments—
Human non-small cell lung carcinoma cell lines A549, H1299,
and H460, human lung L132 fibroblasts, human breast cancer
MCF7 cells, and human embryonic kidney HEK293 cells were
grown in high glucose (25 mM) Dulbecco’s modified Eagle’s
medium (Invitrogen) containing 10% (v/v) fetal bovine serum
(Lonza) and 1% (v/v) antibiotics (Invitrogen) at 37 °C in 5%
CO2. Cells were rinsed with PBS and then cultured in glucose-
free Dulbecco’s modified Eagle’s medium (WelGENE, Inc.)
containing 10% (v/v) fetal bovine serumand 1% (v/v) antibiotics
for up to 36 h. For the inhibitor treatment, cells were cultured in
medium containing either 1 g/ml cycloheximide (Sigma), 20
M 6-Diazo-5-oxo-L-norleucine (DON, Sigma), 20 M Com-
pound C (Calbiochem), or 20 M glycogen phosphorylase
inhibitor (Calbiochem) for 1 h. Afterward, cells were washed
with PBS and incubated in the glucose-freemedium containing
inhibitor.
Transient Overexpression of OGT—Human full-length OGT
was cloned into the p3XFLAG-CMV-7.1 expression vector
(Sigma). The vector encoding FLAG-tagged OGT or empty
vector was transfected using Tranfectin (Bio-Rad).
Cell Lysis, Immunoprecipitation, and WGA Precipitation—
Cells were washed twice in ice-cold PBS and solubilized in lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet
P-40, 1 mM EDTA, and protease inhibitors). The lysates were
centrifuged at 18,000 g for 20min at 4 °C. Protein concentra-
tions were determined by Bradford assay (Bio-Rad). To immu-
noprecipitate FLAG-tagged OGT, 1 mg of a given lysate was
mixed with EZviewTM Red anti-FLAGM2 Affinity Gel (Sigma)
overnight at 4 °C under gentle agitation. Beads were washed
four times with lysis buffer. Pellet was resuspended in 2 SDS
sample buffer. Samples were boiled for 5 min and subjected
to Western blotting. For succinylated wheat germ agglutinin
(sWGA) precipitation, 1mg of cell lysate was incubatedwith 25
l of agarose-sWGA (Vector Laboratories) overnight at 4 °C.
The precipitates were washed with lysis buffer and then eluted
in 2 SDS sample buffer.
Western Blotting—Soluble protein samples or precipitates
were subjected to SDS-PAGE and transferred to nitrocellulose
membranes (GEHealthcare) using a PROTEIN II xi cell system
(Bio-Rad) and mini-TransBlot cell system (Bio-Rad). The
membranes were blocked in 5% skimmedmilk in TBST (20mM
Tris, pH 7.4, 150mM sodium chloride, and 1%Tween 20) for 1 h
at ambient temperature and then incubated overnight at 4 °C in
1% skimmed milk containing diluted primary antibodies. The
following antibodies were used: anti-O-GlcNAc (CTD110.6,
Covance), anti-OGT (DM17, Sigma), anti-actin, anti-glyco-
gen phosphorylase (Santa Cruz Biotechnology), anti-FLAG
(Sigma), anti-AMPK, anti-phospho-AMPK and anti-glycogen
synthase (Cell Signaling). Rabbit polyclonal O-GlcNAcase
antibodies were raised by immunizing two rabbits with human
full-length O-GlcNAcase (AbFrontier). Rabbit polyclonal
glutamine:fructose-6-phosphate amidotransferase (GFAT)
antibodies were kindly provided by Dr. Pann-Ghill Suh
(POSTECH, Pohang, Korea). Afterward, membranes were
washed several times and incubated with horseradish peroxi-
dase-conjugated appropriate secondary antibodies (Santa Cruz
Biotechnology) for 1 h. Following several washes, the mem-
branes were developed using ECL reagent (GE Healthcare) and
then exposed to Medical x-ray Film Blue (Agfa) or Amersham
Biosciences HyperfilmTM ECL (GE Healthcare). Densitometry
measurements were performed using aMulti Gauge version 2.3
program (Fuji Photo Film).
OGT and O-GlcNAcase Assay—OGT activity was measured
in whole cell lysates, which were incubated with reaction buffer
containing recombinant glutathione S-transferase-tagged p62
and 100 M UDP-GlcNAc for 2 h (25). Recombinant glutathi-
one S-transferase-tagged p62 fragment used as substrate for
OGT was extracted from Escherichia coli and purified on glu-
tathione-Sepharose (GEHealthcare). The reactionwas stopped
by the addition of 2 mM glutathione, and supernatants were
mixed with SDS-PAGE sample buffer, subjected to SDS-PAGE,
and immunoblotted using anti-O-GlcNAc antibodies.
O-GlcNAcase assayswere performed as described previously
with minor modifications (10). The whole cell lysates were
incubated with assay buffer (50 mM sodium cacodylate, pH 6.5,
50 mM N-acetylgalactosamine, 2 mM p-nitrophenyl-N-acetyl-
D-glucosaminide) for 1 h at 37 °C. The reaction was stopped by
adding 0.5 M sodium carbonate. Hydrolyzed p-nitrophenol was
measured spectrophotometrically at 400 nm.
GFAT Assay—The GFAT assay was performed as described
previously with minor modifications (26). Cells were washed
with ice-cold PBS andmechanically removed in 500l ofGFAT
buffer (50 mM Tris-HCl, 5 mM EDTA, 5 mM glucose 6-phos-
phate and glutathione, 5mMglucose 6-phophateNa2, and 5mM
KCl, pH7.5). The harvested cells were sonicated andpelleted by
centrifugation (18,000 g, 20 min). Protein concentration was
determined with Bio-Rad protein assay reagent. Samples were
adjusted to the same protein concentration in 500 l of GFAT
buffer. Then 500 l of reaction buffer (0.8 mM D-fructose
6-phosphate, 6.0 mM glutamine, 0.3 mM acetylpyridine adenine
dinucleotide, 50 mM KCl, 0.1 mM KH2PO4, 6 units of glutamic
acid dehydrogenase, pH 7.8) was added to the respective sam-
ples. After incubation for 2 h at 37 °C, changes of absorbance at
370 nm due to the reduction of acetylpyridine adenine dinucle-
otide were measured.
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Periodic Acid-Schiff (PAS) Staining and ATP Content
Determination—The cell plateswere treatedwith 0.5%periodic
acid (Janssen, Geel, Belgium) solution for 10 min. The plates
were rinsed with PBS. Then the cell plates were incubated with
Schiff solution (Muto PureChemicals) overnight, washed in tap
water, and counterstained with Harris hematoxylin. ATP con-
centrations were determined using the ATP Bioluminescent
assay kit (Sigma).
Statistical Analysis—Statistical significance of enzyme activ-
ities or ATP level was determined by unpaired Student’s t test
using Microsoft Excel-based application. Results are expressed
as mean S.E.
RESULTS
Glucose Deprivation Increases Protein O-GlcNAcylation in
A549 Cells—Under glucose deprivation, no significant change
of cellular protein level inA549 cells was detected inCoomassie
Brilliant Blue-stained gels (Fig. 1A). Glucose deprivation was
reported to increase protein O-GlcNAcylation in HepG2 and
Neuro-2a cells (21, 22), and we could confirm this effect for
A549 cells and several other cell lines. As shown in Fig. 1B,
protein O-GlcNAcylation increased under glucose deprivation
to reach a maximum after 24 h and remained at this level for
36 h, the longest time period analyzed. Specificity of the immu-
noblot was verified by competition with 10 mM GlcNAc (Fig.
1B). When glucose-free culture medium was replaced by
medium containing 25 mM glucose, protein O-GlcNAcylation
gradually decreased to reach control levels after 24 h (Fig. 1C).
Increase of O-GlcNAcylation under Glucose Deprivation Is
Not Accompanied by an Increase in OGT or O-GlcNAcase
Protein—The recent studies on HepG2 and Neuro-2a cells
showed that the increase of protein O-GlcNAcylation in
response to glucose deprivation was due to increased OGT (21,
22). We, however, observed no significant change in OGT and
O-GlcNAcase protein in A549 cells by glucose deprivation (Fig.
2A). This is supported by increased O-GlcNAcylation ob-
served under cycloheximide treatment (Fig. 2B). Thus, O-
GlcNAcylation increased by glucose deprivation seems to be
independent of the induction of OGT and O-GlcNAcase.
Glucose Deprivation Enhances OGT Activity and Reduces
O-GlcNAcase Activity—To investigate whether glucose depri-
vation affects the activities of OGT and O-GlcNAcase, we per-
formed OGT and O-GlcNAcase assays with total lysates of
A549 cells. The OGT activity toward the p62 peptide substrate
was increased about 2-fold following 24 h glucose deprivation
(Fig. 3A). However, O-GlcNAcase activity decreased gradually
and was only 60% of control after 36 h of glucose deprivation
(Fig. 3B). Together, these data indicate that increased O-Glc-
NAcylation by glucose deprivation is due to increased OGT
activity and decreased O-GlcNAcase activity.
O-GlcNAcylation on OGT Is Decreased by Glucose Dep-
rivation—Because OGT is known to be O-GlcNAcylated, we
studied the effect of glucose deprivation on O-GlcNAcylation of
FLAG-tagged OGT expressed in A549 cells. As observed for
endogenous OGT (Fig. 2A), the amount of FLAG-OGT
remained unchanged under glucose deprivation (Fig. 4A).
However, O-GlcNAcylation of OGT was greatly reduced (Fig.
4A). In agreement, pull-down ofOGTwith sWGA,which binds
preferentially to terminal GlcNAc (27), showed greatly reduced
OGT compared with control (Fig. 4B). Furthermore, we
observed differences in the pattern of proteinO-GlcNAcylation
between OGT-overexpressing and control cells under glucose
deprivation (Fig. 4C). This indicates that changes of O-Glc-
NAcylation following glucose deprivation are OGT-specific. It
has been reported thatOGT substrate specificity is regulated by
transiently interacting proteins and depends on various cellular
conditions (22, 28). In agreement, our results show that glucose
deprivation not only enhances OGT activity but in addition
affects its substrate specificity.
Hexosamine Biosynthetic Pathway and O-GlcNAc Modifica-
tion in Response to Glucose Deprivation—GFAT is the first and
rate-limiting enzyme for entry of glucose into the HBP. To reveal
a relation between the HBP and increased O-GlcNAcylation
by glucose deprivation, we measured both the amount of
GFAT protein and its activity. Both GFAT protein and activity,
measured by the glutamate dehydrogenase method (26),
increased during glucose deprivation (Fig. 5A). Treatment of
cells with the GFAT inhibitor DON completely blockedO-Glc-
FIGURE 1. Glucose deprivation increases protein O-GlcNAcylation in
A549 cells which is reversible upon glucose replenishment. A and B,
lysates from A549 cells cultured in glucose-free medium for the indicated
time points were stainedwith Coomassie Blue G-250 (A) and immunoblotted
either with O-GlcNAc antibody or O-GlcNAc antibody in 10 mM GlcNAc (B).
C, A549 cells were cultured in glucose-free medium for 24 h, rinsed with PBS,
and subsequently incubated in medium containing 25 mM glucose for the
indicated time points. Total cellular extract (30 g/lane) was separated by
SDS-PAGE, and O-GlcNAc residues were detected by immunoblotting (IB).
CTL, control; GD24, glucose deprivation for 24 h.
O-GlcNAcModification Increases in Glucose-deprived A549
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NAcylation under glucose deprivation (Fig. 5B). These data
indicate a relation between the HBP and increased O-Glc-
NAcylation under conditions of glucose deprivation. However,
glucose deprivation reduced the amount of phosphofructoki-
nase 1 (Fig. 5C) that converts fructose 6-phosphate into fruc-
tose 1,6-bisphosphate under consumption of ATP. Under our
experimental conditions, we also observed that generation of
ATPwas blocked (Fig. 5D). Because ATP is not only a substrate
but also al allosteric inhibitor of phosphofructokinase 1 (for
review, see ref. 29), a possible relationship between the reduc-
tion of phosphofructokinase 1 and the exhaustion of ATP
remains to be clarified. Despite, we conclude that glucose dep-
rivation abolishes the glycolytic pathway in A549 cells.
Increase of O-GlcNAcylation in Response to Glucose Depriva-
tion Occurs through Glycogen Degradation—Because A549 and
H1299 cells contain glycogen (24), we considered glycogen as a
possible source for fructose 6-phosphate in glucose-deprived
cells. By PAS staining, both A549 and H1299 cells contained
glycogen (Fig. 6A) and became PAS-negative after 24 h of glu-
cose deprivation (Fig. 6A). Subsequently, we analyzed GP,
which catalyzes the phosphorylation of glycogen to glucose
1-phosphate. Inhibition of GP prevented the effect of glucose
deprivation onO-GlcNAcylation (Fig. 6B). GP protein in A549
cells remained unchanged during glucose deprivation (Fig. 6C).
When cells were grown in medium containing 25 mM glucose,
inhibition of GP had no effect on O-GlcNAcylation (data not
shown). Together, these data indicate a relation between
increased O-GlcNAcylation by glucose deprivation and glyco-
gen degradation, the latter providing a source for UDP-Glc-
NAc. To analyze the relationship between UDP-GlcNAc levels
FIGURE 2. Increase of O-GlcNAcylation by glucose deprivation is not
accompanied by OGT induction but by O-GlcNAcase reduction and is
independent of de novo protein synthesis. A, lysates from A549 cells cul-
tured in glucose-free medium for the indicated times were resolved by SDS-
PAGE, and membranes were immunoblotted (IB) for OGT and O-GlcNAcase.
B, cells were cultured in the presence of cycloheximide (CHX; 1g/ml) for 1 h,
washed with PBS, and subsequently incubated in the glucose-free medium
containing cycloheximide (1 g/ml) for the indicated times. Total cellular
extract (30 g/lane) was resolved SDS-PAGE, and O-GlcNAc was determined
by immunoblotting. Densitometry measurements were performed using a
Multi Gauge version 2.3 program (Fuji Photo Film).
FIGURE 3. Glucose deprivation increases OGT activity and reduces
O-GlcNAcase activity. A, whole cell lysates from glucose-deprived A549
cells were assayed for OGT activity at the indicated time points as
described under “Experimental Procedures.” The O-GlcNAcylation level of
p62 was taken as measure for OGT activity and normalized to the amount
of p62. IB, immunoblot. B, whole cell lysates from glucose-deprived A549
cells were assayed for O-GlcNAcase activity as described under “Experi-
mental Procedures” for the indicated times. Hydrolyzed p-nitrophenol
was measured spectrophotometrically at 400 nm. **, p  0.01 compared
with control; ***, p  0.001 compared with control. CTL, control; NAG,
1,2-dideoxy-2-methyl--D-glucopyranoso-[2,1-d]-2-thiazoline.
O-GlcNAcModification Increases in Glucose-deprived A549
34780 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 50•DECEMBER 11, 2009
 at Y
O
N
SEI U
N
IV
ERSITY
 on January 21, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
and glycogen breakdown, we measured the intracellular UDP-
GlcNAc levels of glucose-deprived cells under GP inhibitor
treatment. Although UDP-GlcNAc could be detected in con-
trol A549 cells, we were unable to measure UDP-GlcNAc fol-
lowing 24 h of glucose deprivation whether or not GP was
inhibited (supplementary Fig. 1). Most probably, all UDP-Glc-
NAc was rapidly used for O-GlcNAcylation.
Increased O-GlcNAcylation in Response to Glucose Depriva-
tion Is Independent of Activation of AMPK—Next, we investi-
gated the correlation between AMPK and increased O-Glc-
NAcylation by glucose deprivation because AMPK is known to
be a nutrient sensor and activated by glucose depletion (30–
32). Previously, Cheung et al. (22) demonstrated that glucose
deprivation inducesO-GlcNAcylation by OGT induction in an
AMPK-dependent manner in Neuro-2a cells. However, we
obtained no evidence for AMPK dependence of increased
O-GlcNAcylation by glucose deprivation in A549 cells. AMPK
was already phosphorylated in control conditions, and its phos-
phorylation rather decreased than increased following glucose
deprivation (Fig. 7A). In line with this, treatment with the
AMPK inhibitor Compound C did not significantly affect the
patterns of O-GlcNAcylation following glucose deprivation,
albeit the increase ofO-GlcNAcylationwas less prominent (Fig.
7B, compare left two lanes with left two lanes) which may be
FIGURE 4. O-GlcNAcylation on OGT is decreased by glucose deprivation.
A, whole cell lysates from A549 cells transfected with either FLAG vector or
FLAG-tagged OGT were immunoprecipitated (IP) with FLAG antibodies and
immunoblotted (IB) for FLAG andO-GlcNAc. B, whole cell lysates from control
and glucose-deprived A549 cells were precipitated with sWGA-agarose. The
precipitates were separated by SDS-PAGE and immunoblotted for OGT.
C, whole cell lysates from A549 cells transfected with FLAG vector or FLAG-
OGT immunoblotted for O-GlcNAc, FLAG, and -actin. CTL, control; GD24,
glucose deprivation for 24 h.
FIGURE 5. HBP is activated in response to glucose deprivation. A, whole
cell lysates from glucose-deprived A549 cells were assayed for GFAT activity
as described under “Experimental Procedures” at indicated time points. IB,
immunoblot. *, p 0.05 compared with control. B, cells were treated with 20
M DON, washed with PBS, and then incubated with glucose-free medium
containing 20MDON for the indicated time points. Total cellular extract (30
g/lane) was resolved by SDS-PAGE, and O-GlcNAc was detected by immu-
noblotting (IB). C, whole lysates from glucose-deprived A549 cells were
immunoblotted for phosphofructokinase 1 (PFK1) at the indicated time
points.D, ATP content of glucose-deprived A549 cells was determined at the
indicated time points as described under “Experimental Procedures.” ***, p
0.001 compared with control.
O-GlcNAcModification Increases in Glucose-deprived A549
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related to reduced OGT protein expression under Compound
C treatment (Fig. 7A). Recently, Taylor et al. (23) reported no
increase in AMPK pathway activation in glucose-deprived
HepG2 cells. Furthermore, we observed that Compound C
reduced the amount of glycogen synthase but not of GP (Fig.
7A). From this, we speculate that the glycogen metabolism in
A549 cells may be influenced by AMPK through its effect on
glycogen synthase.
Glucose Deprivation Increases O-GlcNAcylation in Various
Cell Lines—To verify that increased O-GlcNAcylation by glu-
cose deprivation is not a particular feature of A549 cells, other
cell lines were studied. As observed for A549 cells, O-Glc-
NAcylation was increased in glucose-deprived H460 and
H1299 cells as well as in HEK293 andMCF7 cells (Fig. 8). Both
H460 cells, another non-small cell lung carcinoma line, and
MCF7 cells, human breast cancer cells, contained glycogen and
became PAS-negative after 24 h of glucose deprivation (supple-
mentary Fig. 2). In contrast,O-GlcNAcylationwas decreased in
glucose-deprived L132 lung fibroblasts (Fig. 8A, right panel).
Thus, glucose deprivation resulted in increased O-Glc-
NAcylation in various carcinoma cell lines and in kidney-derived
embryonic epithelia, but not in lung fibroblasts. Other glycogen-
containing carcinoma cell lines also showed increased O-Glc-
NAcylation following glucose deprivation (data not shown).
DISCUSSION
An increase of O-GlcNAcylation by glucose deprivation was
reported by Taylor et al. (21) for HepG2 cells and by Cheung et
al. (22) forNeuro-2a cells and could be confirmed in the present
study for several other carcinoma cell lines and embryonic kid-
ney epithelia.We havemade the following new observations: (i)
the increased O-GlcNAcylation in A549 cells was due to an
FIGURE6. IncreaseofO-GlcNAcylation in response toglucosedeprivation
occurs through glycogen degradation. A, control and glucose-deprived
A549andH1299cellswere stainedbyPAS reagent asdescribedunder “Exper-
imental Procedures.” PAS-stained cells appear in pink. B, GP inhibitor (20 M)
treatment. Total cell lysates were separated by SDS-PAGE and immuno-
blotted (IB) forO-GlcNAc or stained with Coomassie Blue G-250. C, whole cell
lysates from glucose-deprived A549 cells were immunoblotted for GP.
FIGURE 7. IncreasedO-GlcNAcylation in response to glucose deprivation
is not wholly dependent on activation of AMPK. Cells were cultured in
presence of 20 M Compound C for 1 h, washed with PBS, and incubated in
glucose-free medium containing 20 M Compound C for 24 h. Total cellular
extract (30 g/lane) was resolved by SDS-PAGE and immunoblotted (IB) for
AMPK, pAMPK, OGT, GP, and glycogen synthase (GS) (A) and O-GlcNAc (B).
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increase of OGT activity rather than OGT protein and a con-
current decrease ofO-GlcNAcase activity, and (ii) the increased
O-GlcNAcylation under conditions of glucose deprivation in
the studied cell lines is apparently due to glycogen degradation.
In previous studies by others (21, 22), O-GlcNAcylation
increased by glucose deprivation was found to be paralleled by
induction of OGT. Our analysis of A549 lung carcinoma cells
showed no change in the amount of OGT protein during glu-
cose deprivation but a significant increase in OGT activity as
well as decrease of O-GlcNAcase protein and activity. This
2-fold effect may explain the observed increase of O-Glc-
NAcylation. Interestingly, and in contrast to the increase in
O-GlcNAcylation of cellular proteins, we detected a decrease of
O-GlcNAcylation of OGT itself. This was accompanied not
only by an increase of its activity but also a change in substrate
specificity. Based on these observations, we propose that the
reduced O-GlcNAcylation of OGT has an effect on both its
catalytic activity and substrate specificity. It is known that the
substrate specificity of OGT is regulated by transiently inter-
acting proteins and depends on various cellular conditions (28).
It can be speculated that the O-GlcNAcylation state of OGT
may influence its interaction with such regulatory proteins,
which potentially suggests a regulatory role of O-Glc-
NAcylation for OGT. This proposal should be tested in future
experiments.
Also, we showed that O-GlcNAcase activity decreased
gradually under glucose deprivation without simultaneous
decreases of O-GlcNAcase proteins. We speculate that post-
translational regulation of O-GlcNAcase probably influences
O-GlcNAcase activity under glucose deprivation.
Although certain details of the mechanism leading to in-
creased O-GlcNAcylation upon glucose deprivation are now
established (21, 23, 28), the origin of theUDP-GlcNAc required
for increased O-GlcNAcylation is unknown. Our results indi-
cate that glycogen provides an important source for the needed
glucose because the inhibition of GP, the rate-limiting enzyme
for glycogenolysis, prevented increased O-GlcNAcylation
under glucose deprivation. Furthermore, we demonstrate the
involvement of the HBP by showing an increased amount of
GFAT protein under glucose deprivation and that GFAT inhi-
bition blocked the increased O-GlcNAcylation. Glycogen is a
polymeric form of glucose, which functions as the short term
energy storage in animal cells. It ismost abundant in liver hepa-
tocytes and skeletal muscle fibers, but most other cell types
synthesize some glycogen as well. Muscle glycogen is used to
generate ATP by rapid anaerobic glycolysis, and liver glycogen
is used as a source of glucose that is released into the blood
during fasting (for review, see ref. 33). However the role of gly-
cogen metabolism in other cell types, especially cancer cells, is
notwell understood, even though the carbohydratemetabolism
has long been associated with cancer cells (34). Because of the
limited supply with nutrients and oxygen in rapidly growing
carcinomas, glycogenmay be used by carcinoma cells as source
for energy. As our present study show, cancer cells in culture
use glycogen for O-GlcNAcylation in response to glucose dep-
rivation and not for generating ATP. How can this unexpected
phenomenonbe explained?Under glucose deprivation, energy-
consuming gene transcription and protein synthesis might be
reduced, and protein stability might be increased until glucose
stress is overcome.We hypothesize that the general increase of
O-GlcNAcylation might induce the transient block of gene
transcription and protein synthesis. This is based on the finding
that the highlyO-GlcNAcylatedCTDdomain of RNApolymer-
ase II may inhibit transcriptional elongation induced by phos-
phorylation of CTD (9, 35). Also, O-GlcNAc modification
probably protects proteins from proteasomal degradation via
association byHSP70 (13–15, 19).HSP70 has a lectin-like activ-
ity toward O-GlcNAc (13), and several heat shock proteins
including HSP70 are modified by O-GlcNAc, too (36–38). A
direct link between increased O-GlcNAcylation and the regu-
lation of protein degradation has emerged from studies of pro-
teosomes because it was demonstrated that O-GlcNAcylation
is inhibitory for the 19 S cap of the proteosome (16, 39). Taken
together, we suggest that O-GlcNAcylation may protect pro-
teins from damage under glucose deprivation and therefore,
may help cells to survive as proposed by others (19, 20, 40).
The recent reports (21, 23, 28) and the present study about
increased O-GlcNAcylation under glucose deprivation are
interesting in a more general sense because they demonstrate a
high degree of diversity. The mechanism leading to increased
FIGURE 8. Glucose deprivation increases protein O-GlcNAcylation of
other cell lines except L132 lung fibroblasts.Whole lysates from glucose-
deprived H460, L132, H1299, HEK293T, and MCF7 cells were immunoblotted
(IB) for O-GlcNAc following glucose deprivation at the indicated time points.
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O-GlcNAcylation under glucose deprivation not only seems to
vary in a cell type but also in a metabolism-related manner,
which suggests that further studies on the regulation O-Glc-
NAcylation arewarranted because of its importance for cellular
function.
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